RecruitingNot ApplicableNCT04475640

Cancer Genetic Testing in Ethnic Populations

GEMINI - Cancer Genetic Testing in Ethnic Populations

Sponsor

Mayo Clinic

Enrollment

1,800 participants

Start Date

Jan 13, 2020

Study Type

INTERVENTIONAL

Conditions

Breast Carcinoma Head and Neck Carcinoma Malignant Brain Neoplasm Malignant Solid Neoplasm Skin Carcinoma Carcinoma of Unknown Primary Central Nervous System Carcinoma Digestive System Carcinoma Genitourinary System Carcinoma Malignant Female Reproductive System Neoplasm Malignant Musculoskeletal Neoplasm

Summary

This clinical trial examines the integration of cancer genetic testing in various ethnic populations. Studying individuals and families at risk of cancer may help identify cancer genes and other persons at risk. The information from this study may provide an opportunity for cancer risk stratification and individualized screening in these ethnic populations.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This trial studies how genetic testing results affect cancer treatment decisions and outcomes in patients from diverse ethnic backgrounds, including Hispanic, Native American, African American, and Asian communities. **You may be eligible if...** - You are 18 or older with any solid tumor cancer (breast, GI, gynecologic, skin, brain, etc.) - You self-identify as Hispanic/Latino, Native American, African American, Asian, or another ethnic group - You are receiving treatment or evaluation at Mayo Clinic (Arizona or Florida) - You are able to provide a blood sample and have signed consent **You may NOT be eligible if...** - You already had a 40+ gene panel genetic test at Mayo Clinic within the past 24 months - You have or had a blood cancer (leukemia, multiple myeloma) - You have had a bone marrow transplant Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.